Home NDC 0264-1943 Hyperlyte
Product NDC 0264-1943
11-digit product format 002641943
Labeler code 0264
Product ID 0264-1943_04fffe7e-5bee-4824-a5e4-b1f8b8d1f811
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Multi Electrolyte Concentrate
Dosage form INJECTION, SOLUTION, CONCENTRATE
Route INTRAVENOUS
Labeler B. Braun Medical Inc.
Marketing category UNAPPROVED DRUG OTHER
Marketing start 2012-04-12
Marketing end 0000-00-00
Substance POTASSIUM ACETATE; SODIUM CHLORIDE; SODIUM ACETATE; MAGNESIUM CHLORIDE; CALCIUM CHLORIDE
Active strength 2 g/20mL; g/20mL; g/20mL; g/20mL; g/20mL
Pharmacologic classes Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [CS],Cations, Divalent [CS]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 30 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 0264-1943-20 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 0264-1943-20 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 0264-1943-20 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 0264-1943-20 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 0264-1943-20 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 0264-1943-20 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 0264-1943-20 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 0264-1943-20 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 0264-1943-20 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 0264-1943-20 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 0264-1943-20 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 0264-1943-20 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 0264-1943-20 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 0264-1943-20 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 0264-1943-20 I Inactivated by FDA bd6a592717d7…303034d00443…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CALCIUM CHLORIDE ACTIVE INGREDIENT M4I0D6VV5M HYPERLYTE CR (MULTI ELECTROLYTE CONCENTRATE) INJECTION, SOLUTION, CONCENTRATE [B. BRAUN MEDICAL INC.] 8 MAGNESIUM CHLORIDE ACTIVE INGREDIENT 02F3473H9O HYPERLYTE CR (MULTI ELECTROLYTE CONCENTRATE) INJECTION, SOLUTION, CONCENTRATE [B. BRAUN MEDICAL INC.] 8 POTASSIUM ACETATE ACTIVE INGREDIENT M911911U02 HYPERLYTE CR (MULTI ELECTROLYTE CONCENTRATE) INJECTION, SOLUTION, CONCENTRATE [B. BRAUN MEDICAL INC.] 8 SODIUM ACETATE ACTIVE INGREDIENT 4550K0SC9B HYPERLYTE CR (MULTI ELECTROLYTE CONCENTRATE) INJECTION, SOLUTION, CONCENTRATE [B. BRAUN MEDICAL INC.] 8 SODIUM CHLORIDE ACTIVE INGREDIENT 451W47IQ8X HYPERLYTE CR (MULTI ELECTROLYTE CONCENTRATE) INJECTION, SOLUTION, CONCENTRATE [B. BRAUN MEDICAL INC.] 8 CHLORIDE ION ACTIVE MOIETY Q32ZN48698 HYPERLYTE CR (MULTI ELECTROLYTE CONCENTRATE) INJECTION, SOLUTION, CONCENTRATE [B. BRAUN MEDICAL INC.] 8 POTASSIUM CATION ACTIVE MOIETY 295O53K152 HYPERLYTE CR (MULTI ELECTROLYTE CONCENTRATE) INJECTION, SOLUTION, CONCENTRATE [B. BRAUN MEDICAL INC.] 8 SODIUM CATION ACTIVE MOIETY LYR4M0NH37 HYPERLYTE CR (MULTI ELECTROLYTE CONCENTRATE) INJECTION, SOLUTION, CONCENTRATE [B. BRAUN MEDICAL INC.] 8 WATER INACTIVE INGREDIENT 059QF0KO0R HYPERLYTE CR (MULTI ELECTROLYTE CONCENTRATE) INJECTION, SOLUTION, CONCENTRATE [B. BRAUN MEDICAL INC.] 8
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0264-1943-20 00264194320 12 CONTAINER in 1 CASE (0264-1943-20) > 250 mL in 1 CONTAINER 12 container 2012-04-12 0000-00-00 No No Current